NCT06686667

Brief Summary

The aim of this clinical trial is to assess whether it is feasible for shift workers to follow a time-restricted eating diet. The trial will investigate the impact of time-restricted eating on blood glucose levels during day and night shifts both with and without the time-restricted eating diet. The trial aims are:

  • Is it feasible for shift workers to adhere to a night time time-restricted eating protocol?
  • How does time-restricted eating affect blood glucose levels during the day and night shifts and over the whole day?

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 4, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

November 13, 2024

Completed
4 months until next milestone

Study Start

First participant enrolled

March 24, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 10, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

December 22, 2025

Status Verified

June 1, 2025

Enrollment Period

4 months

First QC Date

November 4, 2024

Last Update Submit

December 15, 2025

Conditions

Keywords

Shift Worker Healthdietary interventiontime restricted eatingfeasibility

Outcome Measures

Primary Outcomes (3)

  • Feasibility of time-restricted eating (TRE) among shift workers (Recruitment and Participation Rate)

    Feasibility will be assessed through a composite of the following metrics: Recruitment and participation rate (%) will be assessed as the percentage of participants randomized from the screened population. Each component will be assessed separately but reported as contributing factors to the overall feasibility.

    From enrolment to end of treatment at 2 weeks

  • Feasibility of time-restricted eating (TRE) among shift workers (Adherence Rate)

    Feasibility will be assessed through a composite of the following metrics: Adherence rate (%) percentage of participants who comply with the TRE protocol over a 2-week period, determined using self-reports Each component will be assessed separately but reported as contributing factors to the overall feasibility.

    Two weeks

  • Feasibility of time-restricted eating (TRE) among shift workers (Study Completion Rate)

    Feasibility will be assessed through a composite of the following metrics: Study completion rate (%) percentage of participants who complete the 2-week study period without dropping out. Each component will be assessed separately but reported as contributing factors to the overall feasibility.

    Two weeks

Secondary Outcomes (2)

  • Blood glucose levels during the 2-week study period

    2 weeks

  • Facilitators and barriers associated with adherence to time restricted eating

    2 weeks

Study Arms (2)

Time Restricted Eating

EXPERIMENTAL

Participants will follow a time-restricted eating diet during day and night shifts over 2 weeks

Behavioral: Time Restricted Eating

Control Arm

NO INTERVENTION

Participants will follow their usual eating patterns without restrictions during day and night shifts over 2 weeks

Interventions

The intervention arm will consist of a time-restricted eating protocol with fasting between 11:00 PM to 6:00 AM. Ad libitum eating will be allowed outside these times and the protocol will be administered during day and night shifts over a 2 week period.

Time Restricted Eating

Eligibility Criteria

Age23 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthcare professionals engaged in rotating shift work, including night shifts;
  • Aged 23-60 years;
  • At least 12 months experience in shift work;
  • Willing to wear continuous glucose monitor sensors;
  • Willing to engage in time restricted eating.

You may not qualify if:

  • Diagnosis of diabetes (Type 1 or 2), any bariatric surgery, coeliac disease, inflammatory bowel disease, endocrine disorders affecting glucose metabolism, current or history of eating disorder, any liver, kidney, or coronary heart disease, obese (BMI\>35) or underweight (BMI\< 18) or any severe or unstable chronic medical conditions or cancers;
  • Currently taking medications known to interact with glucose metabolism, i.e. thyroxin, insulin sensitizers, glucocorticoids, or anti-depressants, weight loss medication;
  • Undertaking current structured or restrictive dietary plan;
  • Shift workers who routinely do not eat between 23:00 and 06:00 hours during night shift;
  • Current or planned pregnancy or currently breast feeding;
  • Consume three or more standard alcohol containing beverages on a single occasion almost every day;
  • People who identify as having significant caffeine dependency and are unwilling to limit intake of calorie free energy drinks;
  • People with planned travel over time zones during the study period
  • Any contraindication to use of Abott FreeStyle Libre Pro glucose sensor (eg prescription of vitamin C, Salicylic acid or paracetamol - to be reviewed by study clinician).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Sutherland Hospital

Caringbah, New South Wales, 2229, Australia

Location

MeSH Terms

Conditions

Feeding BehaviorIntermittent Fasting

Condition Hierarchy (Ancestors)

Behavior, AnimalBehaviorFasting

Study Officials

  • Christopher J Gordon, PhD

    Woolcock Institute of Medical Research and Macquarie University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Open label trial assessing a behavioral eating intervention
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 4, 2024

First Posted

November 13, 2024

Study Start

March 24, 2025

Primary Completion

July 10, 2025

Study Completion

September 1, 2025

Last Updated

December 22, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

All data will be dei-dentified using a unique study ID.

Locations